RIFAXIMIN IS EFFICACIOUS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS PREVIOUSLY TREATED WITH OTHER IBS MEDICATIONS

被引：0
|
作者：
Rao, Satish S.
Schoenfeld, Philip S.
Heimanson, Zeev
Rezaie, Ali
Lacy, Brian E.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1329
引用
收藏
页码：S852 / S852
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [2] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [3] Impact of Colonoscopy Timing on Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Lacy, Brian E.
    Lembo, Anthony
    Pimental, Mark
    Heimanson, Zeev
    Cash, Brooks D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S295 - S295
  • [4] The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D)
    Min, Yang Won
    Rhee, Poong-Lyul
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (03) : 136 - 142
  • [5] Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Rezaie, Ali
    Heimanson, Zeev
    Israel, Robert J.
    McCallum, Richard
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S269 - S269
  • [6] Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): Fact or fiction
    Habba, Saad F.
    MEDICAL HYPOTHESES, 2011, 76 (01) : 97 - 99
  • [7] Analysis of Potential Predictors of Symptom Recurrence in Patients Treated with Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Lembo, Anthony J.
    Rao, Satish
    Wolf, Ray
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S253
  • [8] Infection-Related Safety Profile of Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Chey, William D.
    Lembo, Anthony J.
    Wolf, Ray A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S750 - S751
  • [9] Improvements over Time in Individual Diarrhea-Predominant Irritable Bowel Syndrome Symptoms (IBS-D) with Rifaximin Repeat Treatment
    Pimentel, Mark
    Lembo, Anthony J.
    Wolf, Ray
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S240 - S240
  • [10] RIFAXIMIN REPEAT TREATMENT FOR DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND IMPACT ON CLOSTRIDIUM DIFFICILE INFECTION DEVELOPMENT Mark
    Pimentel, Mark
    Schoenfeld, Philip S.
    Heimanson, Zeev
    Cash, Brooks D.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S332 - S332
12345